Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. | Int J Mol Sci | 2021 | 34445368 | PubTator, text mining | PubMed |
| Molecular Epidemiology of SARS-CoV-2 in Diverse Environmental Samples Globally. | Microorganisms | 2021 | 34442775 | PubTator, text mining | PubMed |
| Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. | Microorganisms | 2021 | 34442677 | PubTator, text mining | PubMed |
| Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review. | Life (Basel) | 2021 | 34440497 | PubTator, text mining | PubMed |
| SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System. | Biomedicines | 2021 | 34440200 | PubTator, text mining | PubMed |
| Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease. | ACS Infect Dis | 2021 | 34437808 | PubTator, text mining | PubMed |
| SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. | PLoS Pathog | 2021 | 34437657 | PubTator, text mining | PubMed |
| A Novel Potentially Recombinant Rodent Coronavirus with a Polybasic Cleavage Site in the Spike Protein. | J Virol | 2021 | 34431700 | PubTator, text mining | PubMed |
| An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies. | J Infect Public Health | 2021 | 34429257 | PubTator, text mining | PubMed |
| Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection. | Immunobiology | 2021 | 34425415 | PubTator, text mining | PubMed |
| Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir. | ACS Pharmacol Transl Sci | 2021 | 34414360 | PubTator, text mining | PubMed |
| Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective. | JMA J | 2021 | 34414310 | PubTator, text mining | PubMed |
| Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients. | Signal Transduct Target Ther | 2021 | 34404759 | PubTator, text mining | PubMed |
| Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. | Proc Natl Acad Sci U S A | 2021 | 34400495 | PubTator, text mining | PubMed |
| Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19. | Phytother Res | 2021 | 34396612 | PubTator, text mining | PubMed |
| Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India. | Front Microbiol | 2021 | 34394051 | PubTator, text mining | PubMed |
| An update of anti-viral treatment of COVID-19 | Turk J Med Sci | 2021 | 34391321 | PubTator, text mining | PubMed |
| Evolutionary trajectory of SARS-CoV-2 and emerging variants. | Virol J | 2021 | 34389034 | PubTator, text mining | PubMed |
| Synthesis and molecular docking study of novel COVID-19 inhibitors. | Turk J Chem | 2021 | 34385863 | PubTator, text mining | PubMed |
| Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. | Cell Death Dis | 2021 | 34385425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=75